author-photo

Jason L. DeHart

University of Utah

13

Papers

687

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Self-replicating RNAs drive protective anti-tumor T cell responses to neoantigen vaccine targets in a combinatorial approach

2020 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (1)
From Foe to Friend: Therapeutic and Commercial Applications of Engineered Viruses

2018
- Jason L. DeHart
- Kurt I. Kamrud
Show All
- Source
- Cite
- Save
Citations (0)
HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.

2009 PLOS Pathogens
Show All
- Source
- Cite
- Save
Citations (121)
Human Immunodeficiency Virus Type 1 Vpr Links Proteasomal Degradation and Checkpoint Activation

2008 Journal of Virology
- Jason L. DeHart
- Vicente Planelles
Show All
- Source
- Cite
- Save
Citations (47)
Human Immunodeficiency Virus Type 1 Vif Induces Cell Cycle Delay via Recruitment of the Same E3 Ubiquitin Ligase Complex That Targets APOBEC3 Proteins for Degradation

2008 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (40)
HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.

2006 PLOS Pathogens
Show All
- Source
- Cite
- Save
Citations (97)
Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr

2006 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (21)
The Ataxia Telangiectasia-Mutated and Rad3-Related Protein Is Dispensable for Retroviral Integration

2005 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (49)
ATR and GADD45α mediate HIV-1 Vpr-induced apoptosis

2005 Cell Death & Differentiation
Show All
- Source
- Cite
- Save
Citations (53)
Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and γ-H2AX focus formation

2004 Molecular and Cellular Biology
Show All
- Source
- Cite
- Save
Citations (112)